Anti-VEGF
The development of therapy with anti-angiogenics or vascular endothelial growth factor inhibitors (anti-VEGF) has marked the beginning of a new era in neovascularization and macular edema treatment. Its main goals are the inhibition of growth and development of new vessels along with the reduction of vascular permeability. The advantages over conventional laser photocoagulation are evident as laser treatment always leaves scars and causes a retinal sensitivity deterioration.
Starting with an outline of treatment principles, this volume covers all aspects of anti-VEGF therapy for ophthalmological disorders. In particular, specific chapters are dedicated to age-related macular degeneration, degenerative myopia, angioid streaks, inflammatory diseases, hereditary dystrophies, retinal vein occlusion, diabetic retinopathy, ocular tumors, as well as anterior segment neovascularization. The book gives an update on the application of anti-VEGF in ocular diseases to general ophthalmologists as well as retina specialists.
Download citation file:
Digital Version
Print Version
Table of Contents
-
1 - 3: Angiostatic and Angiogenic FactorsByHeink de Groot;Heink de GrootAugenklinik, Karlsruhe, GermanySearch for other works by this author on:Vera Schmit-Eilenberger;Vera Schmit-EilenbergerAugenklinik, Karlsruhe, GermanySearch for other works by this author on:Janna Kirchhof;Janna KirchhofAugenklinik, Karlsruhe, GermanySearch for other works by this author on:Albert J AugustinAlbert J AugustinAugenklinik, Karlsruhe, GermanySearch for other works by this author on:
-
4 - 20: Mechanisms of Ocular Angiogenesis and Its Molecular MediatorsByMartin J Siemerink;Martin J SiemerinkaOcular Angiogenesis Group, Department of Ophthalmology, Academic Medical Center, Amsterdam, The Netherlands;Search for other works by this author on:Albert J Augustin;Albert J AugustinbAugenklinik, Karlsruhe, Germany, andSearch for other works by this author on:Reinier O SchlingemannReinier O SchlingemannaOcular Angiogenesis Group, Department of Ophthalmology, Academic Medical Center, Amsterdam, The Netherlands;cNetherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, Amsterdam, The NetherlandsSearch for other works by this author on:
-
21 - 38: Antivascular Endothelial Growth Factors in Age-Related Macular DegenerationByUrsula Schmidt-Erfurth;Ursula Schmidt-ErfurthDepartment of Ophthalmology and Optometry, Medical University Vienna, Vienna, AustriaSearch for other works by this author on:Andreas Pollreisz;Andreas PollreiszDepartment of Ophthalmology and Optometry, Medical University Vienna, Vienna, AustriaSearch for other works by this author on:Christoph Mitsch;Christoph MitschDepartment of Ophthalmology and Optometry, Medical University Vienna, Vienna, AustriaSearch for other works by this author on:Matthias BolzMatthias BolzDepartment of Ophthalmology and Optometry, Medical University Vienna, Vienna, AustriaSearch for other works by this author on:
-
39 - 53: Antivascular Endothelial Growth Factor in Diabetic RetinopathyByPierluigi Iacono;Pierluigi IaconoaFondazione G.B. Bietti per l’Oftalmologia, IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Rome, andSearch for other works by this author on:Maurizio Battaglia Parodi;Maurizio Battaglia ParodibDepartment of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, ItalySearch for other works by this author on:Francesco BandelloFrancesco BandellobDepartment of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, ItalySearch for other works by this author on:
-
54 - 72: Retinal Vein OcclusionsByWolf Buehl;Wolf BuehlDepartment of Ophthalmology and Optometry, Medical University Vienna, Vienna, AustriaSearch for other works by this author on:Stefan Sacu;Stefan SacuDepartment of Ophthalmology and Optometry, Medical University Vienna, Vienna, AustriaSearch for other works by this author on:Ursula Schmidt-ErfurthUrsula Schmidt-ErfurthDepartment of Ophthalmology and Optometry, Medical University Vienna, Vienna, AustriaSearch for other works by this author on:
-
73 - 83: Antivascular Endothelial Growth Factor for Choroidal Neovascularization in Pathologic MyopiaByMaurizio Battaglia Parodi;Maurizio Battaglia ParodiaDepartment of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, andSearch for other works by this author on:Pierluigi Iacono;Pierluigi IaconobFondazione G.B. Bietti per l’Oftalmologia, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, ItalySearch for other works by this author on:Francesco BandelloFrancesco BandelloaDepartment of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, andSearch for other works by this author on:
-
84 - 95: Antivascular Endothelial Growth Factors for Inflammatory Chorioretinal DisordersByMaurizio Battaglia Parodi;Maurizio Battaglia ParodiaDepartment of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan;Search for other works by this author on:Pierluigi Iacono;Pierluigi IaconobFondazione G.B. Bietti per l’Oftalmologia, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy, andSearch for other works by this author on:Frank D Verbraak;Frank D VerbraakcAcademic Medical Center, Department of Ophthalmology, Amsterdam, The NetherlandsSearch for other works by this author on:Francesco BandelloFrancesco BandelloaDepartment of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan;Search for other works by this author on:
-
96 - 106: Antivascular Endothelial Growth Factor Treatment in Pseudoxanthoma Elasticum PatientsByFrank D VerbraakFrank D VerbraakDepartments of Ophthalmology and Biomedical Engineering & Physics, Academic Medical Center, Amsterdam, The NetherlandsSearch for other works by this author on:
-
107 - 110: Antivascular Endothelial Growth Factor in Hereditary DystrophiesByMaurizio Battaglia Parodi;Maurizio Battaglia ParodiaDepartment of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, andSearch for other works by this author on:Pierluigi Iacono;Pierluigi IaconobFondazione G.B. Bietti per l’Oftalmologia, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, ItalySearch for other works by this author on:Francesco BandelloFrancesco BandelloaDepartment of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, andSearch for other works by this author on:
-
111 - 122: Antivascular Endothelial Growth Factor as an Approach for Macular EdemaByP.M. Buchholz;P.M. BuchholzAugenklinik, Karlsruhe, GermanySearch for other works by this author on:A.P. Buchholz;A.P. BuchholzAugenklinik, Karlsruhe, GermanySearch for other works by this author on:A.J. AugustinA.J. AugustinAugenklinik, Karlsruhe, GermanySearch for other works by this author on:
-
123 - 132: Angiogenesis and Vascular Endothelial Growth Factors in Intraocular TumorsByGuy S Missotten;Guy S MissottenaDepartment of Ophthalmology, Catholic University Leuven, Belgium;bDepartment of Ophthalmology, Academic Medical Center, Amsterdam, andSearch for other works by this author on:Reinier O Schlingemann;Reinier O SchlingemannbDepartment of Ophthalmology, Academic Medical Center, Amsterdam, andSearch for other works by this author on:Martine J JagerMartine J JagercDepartment of Ophthalmology, Leiden University, Leiden, The NetherlandsSearch for other works by this author on:
-
133 - 139: Antivascular Endothelial Growth Factors in Anterior Segment DiseasesByStefan Scholl;Stefan SchollAugenklinik, Karlsruhe, GermanySearch for other works by this author on:Janna Kirchhof;Janna KirchhofAugenklinik, Karlsruhe, GermanySearch for other works by this author on:Albert J AugustinAlbert J AugustinAugenklinik, Karlsruhe, GermanySearch for other works by this author on: